Skip to main content
. 2021 Mar 23;13:2745–2753. doi: 10.2147/CMAR.S297868

Table 1.

Relationship Between GAS5 Expression and Clinical Features of CCA Patients

Variables Number of Cases GAS5 Expression χ2 P
High (n=28) Low (n=22)
Gender
 Male 25 13 12 0.321 0.568
 Female 25 15 10
Age (years)
 <60 19 11 8 0.044 0.832
 ≥60 31 17 14
Tumor size (cm)
 <5 20 11 9 0.013 0.907
 ≥5 30 17 13
Lymph node metastasis
 Presence 33 26 7 20.461 <0.001
 Absence 17 2 15
Clinical stage
 I/II 19 6 13 7.417 0.006
 III/IV 31 22 9